Search results
Paul Ehrlich (German: [ˈpaʊl ˈʔeːɐ̯lɪç] ⓘ; 14 March 1854 – 20 August 1915) was a Nobel Prize-winning German physician and scientist who worked in the fields of hematology, immunology, and antimicrobial chemotherapy.
German biochemist Paul Ehrlich (1854–1915) developed a chemical theory to explain the body’s immune response and did important work in chemotherapy, coining the term magic bullet. Ehrlich received the Nobel Prize in Physiology or Medicine in 1908.
Paul Ehrlich was a German medical scientist known for his pioneering work in hematology, immunology, and chemotherapy and for his discovery of the first effective treatment for syphilis. He received the Nobel Prize for Physiology or Medicine in 1908 jointly with Élie Metchnikoff.
Ehrlich had, like so many other discoverers before him, to battle with much opposition before Salvarsan or Neosalvarsan were accepted for the treatment of human syphilis; but ultimately the practical experience prevailed and Ehrlich became famous as one of the main founders of chemotherapy.
Oct 20, 2015 · Ehrlich also tried to apply his magic bullet concept to anticancer chemotherapy. However, in his days, the etiology of cancer remained unknown, and no cancer-specific structures (molecules) had been detected.
Feb 5, 2016 · As Director of the Georg-Speyer-Haus, Paul Ehrlich greatly intensified the production and testing of various chemical compounds; by doing so, he established the principles of chemotherapy, and finally he developed Salvarsan® in his institute.
One hundred years ago, Paul ehrlich, the founder of chemotherapy, received the Nobel Prize for Physiology or Medicine. His postulate of creating ‘magic bullets’ for use in the fight against...
Aug 1, 2010 · Ehrlich is recognized as the “Father of Chemotherapy.” Ehrlich also turned his attention to cancer and studied the relationship of tumors to host animals. With other researchers, he demonstrated the increased malignancy of cells when passed from animal to animal.
It is almost a century since Professor Paul Ehrlich of the Royal Institute for Experimental Therapy in Frankfurt (Germany) gave the address in Pathology on Chemotherapeutics: scientific prin-ciples, methods and results [1]. Many of the key points of Ehrlich’s treatise set the stage for modern therapeutics in the treatment of infectious diseases.
The contribution of the Berlin-based bacteriologist Paul Ehrlich was vital for the production of high-quality anti-diphtheria serum that could be used to passively vaccinate humans against...
